These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1727273

  • 21. Volumetric mangafodipir trisodium-enhanced cholangiography to define intrahepatic biliary anatomy.
    Lee VS, Rofsky NM, Morgan GR, Teperman LW, Krinsky GA, Berman P, Weinreb JC.
    AJR Am J Roentgenol; 2001 Apr; 176(4):906-8. PubMed ID: 11264075
    [No Abstract] [Full Text] [Related]

  • 22. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
    Murakami T, Baron RL, Peterson MS, Oliver JH, Davis PL, Confer SR, Federle MP.
    Radiology; 1996 Jul; 200(1):69-77. PubMed ID: 8657947
    [Abstract] [Full Text] [Related]

  • 23. [Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
    Vogl TJ, Hammerstingl R, Schnell B, Eibl-Eibesfeldt B, Peqios W, Lissner J.
    Bildgebung; 1992 Dec; 59(4):195-9. PubMed ID: 1292771
    [Abstract] [Full Text] [Related]

  • 24. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
    Mühler A, Clément O, Vexler V, Berthezène Y, Rosenau W, Brasch RC.
    Radiology; 1992 Jul; 184(1):207-13. PubMed ID: 1609081
    [Abstract] [Full Text] [Related]

  • 25. Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study.
    Ni Y, Marchal G, Yu J, Rummeny E, Zhang X, Lodemann KP, Baert AL.
    Radiology; 1993 Jul; 188(1):45-51. PubMed ID: 8390071
    [Abstract] [Full Text] [Related]

  • 26. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
    Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV.
    Radiographics; 2009 Oct; 29(6):1725-48. PubMed ID: 19959518
    [Abstract] [Full Text] [Related]

  • 27. Functional MR cholangiography: diagnosis of functional abnormalities of the gallbladder and biliary tree.
    Fayad LM, Kamel IR, Mitchell DG, Bluemke DA.
    AJR Am J Roentgenol; 2005 May; 184(5):1563-71. PubMed ID: 15855116
    [Abstract] [Full Text] [Related]

  • 28. A segmental hyperintensity area in the liver shown by delayed MR images with Mn-DPDP.
    Suto Y, Weinreb JC, Rofski NM.
    J Comput Assist Tomogr; 1996 May; 20(4):647-9. PubMed ID: 8708073
    [Abstract] [Full Text] [Related]

  • 29. Manganese dipyridoxyl diphosphate (MnDPDP)-enhanced magnetic resonance imaging of acute reperfused myocardial injury in a cat model: part II: comparison with cine magnetic resonance imaging.
    Yang DH, Kim TH, Choi JW, Kim ST, Yoon JH, Shin JH, Seo JB, Lim TH.
    Invest Radiol; 2005 Jan; 40(1):56-61. PubMed ID: 15597021
    [Abstract] [Full Text] [Related]

  • 30. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
    Karabacakoğlu A, Adigüzel Y, Karaköse S, Kayaçetin E, Haykir R.
    Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
    [Abstract] [Full Text] [Related]

  • 31. Contrast-enhanced magnetic resonance cholangiography using mangafodipir compared with standard T2W MRC sequences: a pictorial essay.
    Sheppard D, Allan L, Martin P, McLeay T, Milne W, Houston JG.
    J Magn Reson Imaging; 2004 Aug; 20(2):256-63. PubMed ID: 15269951
    [Abstract] [Full Text] [Related]

  • 32. Hepatobiliary contrast material: a magic bullet for sensitivity and specificity?
    Mitchell DG.
    Radiology; 1993 Jul; 188(1):21-2. PubMed ID: 8511300
    [No Abstract] [Full Text] [Related]

  • 33. Unexpected MR-T1 enhancement of endocrine liver metastases with mangafodipir.
    Mathieu D, Coffin C, Kobeiter H, Caseiro-Alves F, Mahfouz A, Rahmouni A, Diche T.
    J Magn Reson Imaging; 1999 Aug; 10(2):193-5. PubMed ID: 10441024
    [Abstract] [Full Text] [Related]

  • 34. Mn-DPDP-enhanced 24-h delayed-scan MRI of hepatocellular carcinoma is correlated with histology.
    Wang DB, Zhou KR, Zeng MS, Chen KM, Wang YX.
    Eur Radiol; 2004 Apr; 14(4):743-5. PubMed ID: 12802614
    [No Abstract] [Full Text] [Related]

  • 35. Uptake of mangafodipir trisodium (MnDPDP) by hepatocellular carcinoma: correlation with unenhanced imaging findings and histopathologic features.
    Chezmar JL, Redvanly RD, Sewell CW.
    Acad Radiol; 1996 Aug; 3 Suppl 2():S413-4. PubMed ID: 8796617
    [No Abstract] [Full Text] [Related]

  • 36. [MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].
    Ba-Ssalamah A, Happel B, Kettenbach J, Dirisamer A, Wrba F, Längle F, Schima W.
    Radiologe; 2004 Dec; 44(12):1170-84. PubMed ID: 15551031
    [Abstract] [Full Text] [Related]

  • 37. Contrast-enhanced magnetic resonance imaging of the liver with Mn-DPDP for known or suspected focal hepatic disease.
    Bernardino ME, Young SW, Lee JK, Weinreb J.
    Invest Radiol; 1991 Nov; 26 Suppl 1():S148-9; discussion S150-5. PubMed ID: 1808113
    [No Abstract] [Full Text] [Related]

  • 38. Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images.
    Liou J, Lee JK, Borrello JA, Brown JJ.
    Magn Reson Imaging; 1994 Nov; 12(1):71-9. PubMed ID: 8295510
    [Abstract] [Full Text] [Related]

  • 39. Clinical hepatic imaging with paramagnetic positive enhancers.
    Bernardino ME.
    Magn Reson Med; 1991 Dec; 22(2):334-8; discussion 343-6. PubMed ID: 1812367
    [No Abstract] [Full Text] [Related]

  • 40. Contrast-enhanced MR imaging of the liver.
    Runge VM, Pels Rijcken TH, Davidoff A, Wells JW, Stark DD.
    J Magn Reson Imaging; 1994 Dec; 4(3):281-9. PubMed ID: 8061423
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.